Grants per year
Personal profile
Training Experience
| 2010 | Postdoctoral Fellowship, Northwestern University Feinberg School of Medicine |
Education/Academic qualification
PhD, University of Rostock
… → 1995
MD, University of Rostock
… → 1994
Fingerprint
Dive into the research topics where Jan Wysocki is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 3 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
-
NCR-19-2039- Ammonium excretion in ZS-9 treated mice with CKD
AstraZeneca Pharmaceuticals LP
5/26/20 → 5/31/21
Project: Research project
-
Urinary Renin Angiotensin System in Diabetes
Molitch, M. E., Rademaker, A. W., Wysocki, J. & Batlle, D.
National Institute of Diabetes and Digestive and Kidney Diseases
6/15/15 → 4/30/20
Project: Research project
-
ACE2 as Therapeutic Target for Kidney Disease in Diabetic Mice
12/1/07 → 6/30/11
Project: Research project
Research Output
-
An update on ACE2 amplification and its therapeutic potential
Marquez, A., Wysocki, J., Pandit, J. & Batlle, D., Jan 2021, In: Acta Physiologica. 231, 1, e13513.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery
Lores, E., Wysocki, J. & Batlle, D., Nov 1 2020, In: Clinical science. 134, 21, p. 2791-2805 15 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent
Serfozo, P., Wysocki, J., Gulua, G., Schulze, A., Ye, M., Liu, P., Jin, J., Bader, M., Myöhänen, T., García-Horsman, J. A. & Batlle, D., Jan 1 2020, In: Hypertension (Dallas, Tex. : 1979). 75, 1, p. 173-182 10 p.Research output: Contribution to journal › Article › peer-review
46 Scopus citations -
Interaction of SARS-CoV-2 and other coronavirus with ACE (angiotensin-converting enzyme)-2 as their main receptor: Therapeutic implications
Davidson, A. M., Wysocki, J. & Batlle, D., 2020, (Accepted/In press) In: Hypertension. p. 1339-1349 11 p.Research output: Contribution to journal › Review article › peer-review
4 Scopus citations -
Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19
Wysocki, J., Lores, E., Ye, M., Soler, M. J. & Batlle, D., Sep 2020, In: Journal of the American Society of Nephrology. 31, 9, p. 1941-1943 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access12 Scopus citations